In Latest News, Publication and DataPosted November 3, 2023 Tallac Presents First Clinical Data for TAC-001 at SITC 2023
In Latest NewsPosted September 27, 2023 Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
In Latest NewsPosted January 19, 2023 Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer